Tysabri and Visual field defect - a phase IV clinical study of FDA data

Summary:

Visual field defect is reported as a side effect among people who take Tysabri (natalizumab), especially for people who are female, 50-59 old, have been taking the drug for 2 - 5 years also take Avonex, and have Depression.

The phase IV clinical study analyzes which people have Visual field defect when taking Tysabri. It is created by eHealthMe based on reports of 220,870 people who have side effects when taking Tysabri from the FDA, and is updated regularly.

What is Tysabri?

Tysabri has active ingredients of natalizumab. It is often used in multiple sclerosis. eHealthMe is studying from 221,369 Tysabri users. Check the latest studies of Tysabri.

What is Visual field defect?

Visual field defect is found to be associated with 768 drugs and 1,037 conditions by eHealthMe. Check the latest studies of Visual field defect.

On Jul, 12, 2026

220,870 people reported to have side effects when taking Tysabri.
Among them, 122 people (0.06%) have Visual field defect.

Could Tysabri cause Visual field defect?

Among these 122 people:

How long have people been on Tysabri when they have Visual field defect? *

Click here to view more results

What is the gender of people who have Visual field defect when taking Tysabri? *

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Tysabri and have Visual field defect?

- Check whether Visual field defect is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tysabri:

Tysabri (221,369 reports)

Visual field defect treatments and more:

Visual field defect (8,900 reports)

How severe was Visual field defect and when was it recovered:

Visual field defect in Tysabri

Expand to all the drugs that have ingredients of natalizumab:

Visual field defect and drugs with ingredients of natalizumab (124 reports)

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Tysabri:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Visual field defect:

Visual field defect (768 drugs)

Browse all the conditions that are associated with Visual field defect:

Visual field defect (1,037 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on natalizumab (the active ingredients of Tysabri) and Tysabri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.